Quarterly report [Sections 13 or 15(d)]

Revenue Recognition (Tables)

v3.26.1
Revenue Recognition (Tables)
3 Months Ended
Mar. 31, 2026
Revenue from Contract with Customer [Abstract]  
Schedule of Revenue by Service Line

Revenue by Service Line

 

Three Months Ended March 31,

 

(in thousands)

 

2026

 

 

2025

 

Biologics and drug delivery

 

 

 

 

 

 

Disposable products

 

$

1,895

 

 

$

1,780

 

Services and license fees

 

 

2,913

 

 

 

2,911

 

Subtotal – Biologics and drug delivery revenue

 

 

4,808

 

 

 

4,691

 

Neurosurgery navigation and therapy

 

 

 

 

 

 

Disposable products

 

 

5,887

 

 

 

3,277

 

Subtotal – Neurosurgery navigation and therapy revenue

 

 

5,887

 

 

 

3,277

 

Capital equipment and software

 

 

 

 

 

 

Systems and software products

 

 

1,020

 

 

 

234

 

Services

 

 

413

 

 

 

283

 

Subtotal – Capital equipment and software revenue

 

 

1,433

 

 

 

517

 

Total revenue

 

$

12,128

 

 

$

8,485

 

 

Schedule of Other Current Assets

(in thousands)

 

March 31, 2026

 

 

December 31, 2025

 

Accounts receivable, net

 

$

8,662

 

 

$

6,549

 

Other contract assets

 

 

 

 

 

 

Unbilled receivables

 

$

775

 

 

$

714

 

Deferred contract costs

 

$

 

 

$

150

 

Schedule of Revenue Recognized by Contract Liability The unearned portion of all such fees is classified as contract liabilities.

(in thousands)

 

March 31, 2026

 

 

December 31, 2025

 

Contract liabilities

 

$

2,422

 

 

$

2,250